Clinical Research

EFFECTS OF DIOSMIN ADMINISTRATION ON CISPLATIN-INDUCED PREMATURE OVARIAN FAILURE IN A RAT MODEL

Volume: 12 Number: 6 November 30, 2022
EN TR

EFFECTS OF DIOSMIN ADMINISTRATION ON CISPLATIN-INDUCED PREMATURE OVARIAN FAILURE IN A RAT MODEL

Abstract

m We aimed to examine the potential beneficial effects of diosmin administration on cisplatin - induced premature ovarian failure (POF) in a rat model Material and Methods Twenty-eight rats were divided into four groups. Group A rats (n:7) were determined as the sham group. The remaining rats received an intraperitoneal injection of 1.5 mg/kg/day cisplatin for 10 days to create a POF model. Then, they were randomly divided into 3 subgroups. Group B was determined as POF group. Group C rats were given 100mg/kg/day diosmin for 10 days simultaneously while creating POF model. Group D rats were given 100mg/kg/day diosmin for 10 days after POF model was created. Twentieth day blood samples were taken and left ovaries were resected for examination. Results CIS-induced rats showed reduced levels of SOD, AMH and E2 compared to sham group rats (p<0.05). SOD, AMH and E2 values were not significantly different (p>0.05) between the sham group, group C and D. No significant (p>0.05) difference in FSH value was observed between group C, D and sham groups. There was no significant (p>0.05) difference in the number of secondary and antral follicles between group C and D compared to the sham group. Primordial follicle count was significantly higher in group C than group B (p<0.05). Primary and total follicle count in group D was significantly (p<0.05) higher than group B. Conclusion Diosmin administration after chemotherapy or in combination with chemotherapy has shown helpful efficacy in maintaining the ovarian reserve and the structure of the follicles.

Keywords

Supporting Institution

Yok

Project Number

Yok

References

  1. Referans1. Beck-Peccoz P, Persani L. Premature ovarian failure. Orphanet J Rare Dis. 2006;1:9. Published 2006 Apr 6. doi:10.1186/1750-1172-1-9
  2. Referans2. Mauri D, Gazouli I, Zarkavelis G, et al. Chemotherapy Associated Ovarian Failure. Front Endocrinol (Lausanne). 2020;11:572388. Published 2020 Dec 8. doi:10.3389/fendo.2020.572388
  3. Referans3. Molina JR, Barton DL, Loprinzi CL. Chemotherapy-induced ovarian failure: manifestations and management. Drug Saf. 2005;28(5):401-416. doi:10.2165/00002018-200528050-00004
  4. Referans4. Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol. 1986;67(4):604-606.
  5. Referans5. Blumenfeld Z, Evron A. Endocrine prevention of chemotherapy-induced ovarian failure. Curr Opin Obstet Gynecol. 2016;28(4):223-229. doi:10.1097/GCO.0000000000000278
  6. Referans6. Woad KJ, Watkins WJ, Prendergast D, Shelling AN. The genetic basis of premature ovarian failure. Aust N Z J Obstet Gynaecol. 2006;46(3):242-244. doi:10.1111/j.1479-828X.2006.00585.x
  7. Referans7. Bines J, Oleske DM, Cobleigh MA. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol. 1996;14(5):1718-1729. doi:10.1200/JCO.1996.14.5.1718
  8. Referans8. Huwait E, Mobashir M. Potential and Therapeutic Roles of Diosmin in Human Diseases. Biomedicines. 2022;10(5):1076. Published 2022 May 6. doi:10.3390/biomedicines10051076

Details

Primary Language

English

Subjects

Health Care Administration

Journal Section

Clinical Research

Publication Date

November 30, 2022

Submission Date

August 24, 2022

Acceptance Date

September 5, 2022

Published in Issue

Year 2022 Volume: 12 Number: 6

APA
Gürsoy, A., & Sade, A. G. (2022). EFFECTS OF DIOSMIN ADMINISTRATION ON CISPLATIN-INDUCED PREMATURE OVARIAN FAILURE IN A RAT MODEL. Journal of Contemporary Medicine, 12(6), 912-916. https://doi.org/10.16899/jcm.1166435
AMA
1.Gürsoy A, Sade AG. EFFECTS OF DIOSMIN ADMINISTRATION ON CISPLATIN-INDUCED PREMATURE OVARIAN FAILURE IN A RAT MODEL. J Contemp Med. 2022;12(6):912-916. doi:10.16899/jcm.1166435
Chicago
Gürsoy, Ali, and Ayşe Gökçen Sade. 2022. “EFFECTS OF DIOSMIN ADMINISTRATION ON CISPLATIN-INDUCED PREMATURE OVARIAN FAILURE IN A RAT MODEL”. Journal of Contemporary Medicine 12 (6): 912-16. https://doi.org/10.16899/jcm.1166435.
EndNote
Gürsoy A, Sade AG (November 1, 2022) EFFECTS OF DIOSMIN ADMINISTRATION ON CISPLATIN-INDUCED PREMATURE OVARIAN FAILURE IN A RAT MODEL. Journal of Contemporary Medicine 12 6 912–916.
IEEE
[1]A. Gürsoy and A. G. Sade, “EFFECTS OF DIOSMIN ADMINISTRATION ON CISPLATIN-INDUCED PREMATURE OVARIAN FAILURE IN A RAT MODEL”, J Contemp Med, vol. 12, no. 6, pp. 912–916, Nov. 2022, doi: 10.16899/jcm.1166435.
ISNAD
Gürsoy, Ali - Sade, Ayşe Gökçen. “EFFECTS OF DIOSMIN ADMINISTRATION ON CISPLATIN-INDUCED PREMATURE OVARIAN FAILURE IN A RAT MODEL”. Journal of Contemporary Medicine 12/6 (November 1, 2022): 912-916. https://doi.org/10.16899/jcm.1166435.
JAMA
1.Gürsoy A, Sade AG. EFFECTS OF DIOSMIN ADMINISTRATION ON CISPLATIN-INDUCED PREMATURE OVARIAN FAILURE IN A RAT MODEL. J Contemp Med. 2022;12:912–916.
MLA
Gürsoy, Ali, and Ayşe Gökçen Sade. “EFFECTS OF DIOSMIN ADMINISTRATION ON CISPLATIN-INDUCED PREMATURE OVARIAN FAILURE IN A RAT MODEL”. Journal of Contemporary Medicine, vol. 12, no. 6, Nov. 2022, pp. 912-6, doi:10.16899/jcm.1166435.
Vancouver
1.Ali Gürsoy, Ayşe Gökçen Sade. EFFECTS OF DIOSMIN ADMINISTRATION ON CISPLATIN-INDUCED PREMATURE OVARIAN FAILURE IN A RAT MODEL. J Contemp Med. 2022 Nov. 1;12(6):912-6. doi:10.16899/jcm.1166435

Cited By